Skip to content
Peoria Shoulder Signal
A northwest Valley research dispatch

Peoria Shoulder Signal

What do people ask about a sore shoulder?

Why does shoulder soreness linger, and what can help? A tendon, stiffness, joint wear, an old injury or the neck may be involved. The answers below cover what to try, signs that need quick help and clinic choices.

Begin with how your ache started and what your arm can do now.

What usually causes shoulder soreness?

Soreness may begin in shoulder muscles or tendons known together as the rotator cuff. They hold and lift your arm. Stiffness, joint wear, an old injury or trouble in the neck can also cause an ache. A sore tendon often complains after lifting or reaching. A frozen shoulder stays stiff in several directions. An exam checks your motion, strength and tender area.

Does a bad-looking scan always explain the ache?

No. Scans often show rotator cuff changes in people whose shoulders don't hurt. Your image becomes more useful if it agrees with an injury, weakness or lost motion. It can help after a fall or during a talk about surgery. The person examining you still compares the scan with your strength and movement.

What can I do at home for a sore shoulder?

Reduce the reaching or lifting that starts your ache, but keep easy movement. Cold or warmth may calm a flare. You can start gentle strength work below shoulder height and build slowly. Get examined when weakness appears, soreness rises sharply or your usual arm use keeps getting harder.

When does shoulder soreness need urgent care?

Seek quick care after an accident if your shoulder looks out of place, won't move or suddenly loses strength. A hot, red and swollen shoulder with fever also needs fast care. Call emergency services when shoulder soreness comes with chest tightness, sweating, nausea, jaw trouble or breathlessness.

What is PRP for shoulder pain?

PRP stands for platelet-rich plasma. Clinic staff spin blood and keep its platelet-heavy portion. Clinics may keep different amounts of platelets or white blood cells. A shoulder study found similar early results with PRP and cortisone. At six months, the PRP group used the arm a little better and reported eight-tenths of a point less soreness. The small difference didn't show that the tendon grew back.

Where can I discuss shoulder options in Peoria?

Take your scan report and note the movements that hurt. Ask why the proposed care fits your exam, its total cost and the likely number of return visits. Regenerative treatments are made from blood or other body tissue, though the name doesn't mean a tendon will regrow. At 13128 N. 94th Dr., Suite 205, QC Kinetix medical providers, meaning the people who examine your shoulder, discuss PRP and other non-surgical choices.

Sources

  1. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

    Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

  2. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit.

    Awad G, et al. — Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.. Clinical rheumatology, 2026. DOI: 10.1007/s10067-026-08042-w.

  3. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

  4. The August 2025 AAOS Evidence-Based Clinical Practice Guideline on Management of Rotator Cuff Injuries issued 25 recommendations and 4 consensus statements. Among its updates it clearly RESTRICTS the use of platelet-rich plasma and marrow stimulation in rotator cuff repair, limits prolotherapy in full-thickness tears, establishes CT as an adjunctive imaging modality, and endorses early mobilization after repair of small-to-medium tears.

    Ye Y, et al. — [Interpretation of the 2025 American Academy of Orthopaedic Surgeons (AAOS) on Management of Rotator Cuff Injuries Evidence-Based Clinical Practice Guideline].. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2026. DOI: 10.7507/1002-1892.202511084.

  5. In a nationally representative Finnish population sample of 602 adults aged 41-76 who had bilateral 3-Tesla shoulder MRI regardless of symptoms, rotator cuff abnormalities were found in 98.7% of participants (25% tendinopathy, 62% partial-thickness tear, 11% full-thickness tear). Abnormalities were present in 96% of ASYMPTOMATIC shoulders. Only full-thickness tears were more common in symptomatic shoulders, and that difference all but disappeared after adjustment (absolute difference 0.8%, 95% CI -3.4% to 6.0%).

    Ibounig T, et al. — Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging.. JAMA Intern Med, 2026. DOI: 10.1001/jamainternmed.2025.7903.

  6. A 2026 meta-analysis of 10 randomized trials (n=591) found PRP and corticosteroid indistinguishable at 3-6 weeks and 3 months, with PRP pulling ahead at 6 months: ASES +10.8 (95% CI 4.71-16.80), Constant-Murley +10.7 (1.21-20.27) and VAS pain -0.8 (-1.45 to -0.18), plus fewer adverse events (RR 0.66, 0.44-0.99). The authors describe the benefit as statistically significant but CLINICALLY MODEST.

    Yuwarungsikul C, et al. — Platelet-rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta-analysis of randomized controlled trials.. Knee Surg Sports Traumatol Arthrosc, 2026. DOI: 10.1002/ksa.70416.

Want to ask the clinic about your shoulder?

QC Kinetix offers a Peoria visit to discuss PRP, or platelet-rich plasma from a platelet-heavy portion of spun blood. Other regenerative options may use blood or body tissue. Take your scan report, note the painful motions and ask about visits, cost and time away from normal activity. Call (602) 837-PAIN to check availability.

Talk to the clinic team